Old Web
English
Sign In
Acemap
>
authorDetail
>
Colin Hickle
Colin Hickle
University of California, Berkeley
Biology
In vivo
Immunology
Antibody-drug conjugate
Dosing
4
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Tandem-Cleavage Linkers Improve the In Vivo Stability and Tolerability of Antibody-Drug Conjugates
2021
bioRxiv
Stepan Chuprakov
Ayodele O. Ogunkoya
Robyn M. Barfield
Maxine Bauzon
Colin Hickle
Yun-Cheol Kim
Dominick Yeo
Fangjiu Zhang
David Rabuka
Penelope M. Drake
Show All
Source
Cite
Save
Citations (0)
A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels
2020
bioRxiv
Robyn M. Barfield
Yun-Cheol Kim
Stepan Chuprakov
Fangjiu Zhang
Maxine Bauzon
Ayodele O. Ogunkoya
Dominick Yeo
Colin Hickle
Mark D. Pegram
David Rabuka
Penelope M. Drake
Show All
Source
Cite
Save
Citations (0)
A novel HER2-targeted antibody-drug conjugate offers the possibility of clinical dosing at trastuzumab-equivalent exposure levels.
2020
Molecular Cancer Therapeutics
Robyn M. Barfield
Yun-Cheol Kim
Stepan Chuprakov
Fangjiu Zhang
Maxine Bauzon
Ayodele O. Ogunkoya
Dominick Yeo
Colin Hickle
Mark D. Pegram
David Rabuka
Penelope M. Drake
Show All
Source
Cite
Save
Citations (4)
A CpG-Ficoll Nanoparticle Adjuvant for Anthrax Protective Antigen Enhances Immunogenicity and Provides Single-Immunization Protection against Inhaled Anthrax in Monkeys
2016
Journal of Immunology
Melissa A. Kachura
Colin Hickle
Sariah A. Kell
Atul Sathe
Carlo Calacsan
Radwan Kiwan
Brian E. Hall
Robert Milley
Gary Ott
Robert L. Coffman
Holger Kanzler
John D. Campbell
Show All
Source
Cite
Save
Citations (22)
1